PAB Patrys secures ethics approval for Phase 1A clinical trial on delirium candidate Patrys has received HREC approval to commence its Phase 1A clinical trial of RLS-2202 for the treatment of delirium in acute care settings. Colin Sandell-Hay 2 days ago ASX News Healthcare Biotechnology
MSB Mesoblast completes Phase 3 low back pain trial treatment as pivotal readout approaches Mesoblast has completed treatment of 350 patients in its pivotal Phase 3 trial for chronic low back pain, with results expected in mid-2027. Seja Al Zaidi 17 Aug 2026 16:40 (AEST) Editorial Content Healthcare Biotechnology
AVH AVITA Medical raises 2026 outlook after record second quarter AVITA Medical has raised its 2026 revenue guidance after delivering record quarterly revenue, while forecasting cash flow breakeven by fourth quarter. Seja Al Zaidi 07 Aug 2026 14:30 (AEST) Editorial Content Healthcare Biotechnology
NOX Noxopharm adds to cancer treatment pipeline with positive new study results Noxopharm’s new preclinical data has demonstrated the potential of its cancer-fighting technology and immune-amplifying oligonucleotides. Colin Sandell-Hay 04 Aug 2026 10:25 (AEST) ASX News Healthcare Biotechnology
PAR Paradigm completes Phase 3 enrolment as Zilosul trial moves toward interim analysis Paradigm Biopharmaceuticals has completed enrolment in its Phase 3 knee osteoarthritis trial, with top-line results expected in Q1 2027. Seja Al Zaidi 30 Jul 2026 11:48 (AEST) ASX News Healthcare Biotechnology
PEB Pacific Edge's APAC operations advancing towards profit with cancer test growth Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest in its testing services. Colin Sandell-Hay 14 Jul 2026 09:44 (AEST) ASX News Healthcare Biotechnology
NOX Noxopharm welcomes award of childbirth MRFF grant for Sofra platform Noxopharm has welcomed the awarding of a $1 million medical research future fund grant for a project involving the company’s Sofra platform. Colin Sandell-Hay 02 Jul 2026 12:37 (AEST) ASX News Healthcare Steel Biotechnology Basic Materials
1AI Algorae secures NSW Health hospital supply agreement through AlgoraeRx Algorae Pharmaceuticals has secured a NSW Health standing offer arrangement through its AlgoraeRx division. Seja Al Zaidi 02 Jul 2026 11:49 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys secures exclusive $430K Thailand distribution deal for Felix sperm system Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system. The exclusive contract guarantees A$430,500 over its three-year term, boosting the company’s South-East Asian revenue to A$1 million and driving total FY2... Isaac McIntyre 01 Jul 2026 10:21 (AEST) ASX News Healthcare Biotechnology
NEU Neuren Pharmaceuticals welcomes milestone approval for Daybu Neuren Pharmaceuticals has received positive news for the proposed marketing of the Daybu treatment of Rett syndrome. Colin Sandell-Hay 29 Jun 2026 09:53 (AEST) ASX News Healthcare Biotechnology
MEM Memphasys secures UK market entry, accelerating commercial rollout Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to trial its Felix system. Seja Al Zaidi 25 Jun 2026 11:52 (AEST) ASX News Healthcare Biotechnology
PAR Paradigm Biopharma completes enrolment in pivotal Phase 3 osteoarthritis trial Welcome to HotCopper’s latest Watchlist, where we’ve this week been joined by Paradigm Biopharmaceuticals (ASX:PAR) managing director Paul Rennie to talk about what’s next after the company just cracked another @major milestone&CloseCurlyDoubleQuote... Isaac McIntyre 16 Jun 2026 14:10 (AEST) ASX News The Watchlist Healthcare Biotechnology
MEM Memphasys lands national Monash IVF supply deal for Felix system Memphasys has secured a 12-month exclusive national supply agreement with Monash IVF for its Felix sperm selection system. Seja Al Zaidi 16 Jun 2026 11:45 (AEST) ASX News Healthcare Biotechnology
